{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:14:24Z","timestamp":1774941264039,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cgh.2019.06.028","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T10:07:16Z","timestamp":1561457236000},"page":"693-699.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy"],"prefix":"10.1016","volume":"18","author":[{"given":"Seung Up","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Seok","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Na","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1692-6126","authenticated-orcid":false,"given":"Eun Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Yan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Rim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Yong","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwang-Hyub","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Gyu","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu Sung","family":"Rim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Ho","family":"Um","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1914-5141","authenticated-orcid":false,"given":"Won Young","family":"Tak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Oh","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2019.06.028_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.06.028_bib2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2019.06.028_bib3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","article-title":"Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy","volume":"62","author":"Papatheodoridis","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.028_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cgh.2019.06.028_bib5","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1200\/JCO.2009.26.2675","article-title":"Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers","volume":"28","author":"Wong","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cgh.2019.06.028_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jhep.2008.07.023","article-title":"Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B","volume":"50","author":"Yuen","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.028_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ajg.2014.157","article-title":"Prediction of development of liver-related events by transient elastography in hepatitis B patients with complete virological response on antiviral therapy","volume":"109","author":"Lee","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.06.028_bib8","doi-asserted-by":"crossref","first-page":"s435","DOI":"10.1016\/S0168-8278(14)61235-6","article-title":"PAGE-B: risk score for hepatocellular carcinoma (HCC) development in Caucasian chronic hepatitis B (CHB) patients receiving entecavir (ETV) or tenofovir (TDF)","volume":"60","author":"Papatheodoridis","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.028_bib9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.028_bib10","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jhep.2018.07.018","article-title":"Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy","volume":"69","author":"Kim","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.028_bib11","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/hep.28115","article-title":"Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy","volume":"62","author":"Jung","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.06.028_bib12","first-page":"87","article-title":"Hepatocellular carcinoma prediction models for patients with chronic hepatitis B virus infection in the era of potent antiviral therapy","volume":"18","author":"Lee","year":"2018","journal-title":"J\u00a0Liver Cancer"},{"key":"10.1016\/j.cgh.2019.06.028_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2018.02.032","article-title":"Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B","volume":"69","author":"Hsu","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.028_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3350\/cmh.2012.18.2.109","article-title":"KASL clinical practice guidelines: management of chronic hepatitis B","volume":"18","year":"2012","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2019.06.028_bib15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.24121","article-title":"Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver\u00a0stiffness measurement (FibroScan)","volume":"53","author":"Jung","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.06.028_bib16","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes\u20132019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cgh.2019.06.028_bib17","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.06.028_bib18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.028_bib19","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/hep.29660","article-title":"Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: results from\u00a0two prospective cohort studies","volume":"67","author":"Simon","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.06.028_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fendo.2014.00010","article-title":"The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells","volume":"5","author":"Malaguarnera","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.cgh.2019.06.028_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.bbrc.2008.04.151","article-title":"The anti-apoptotic effect of IGF-1 on tissue resident stem cells is mediated via PI3-kinase dependent secreted frizzled related protein 2 (Sfrp2) release","volume":"371","author":"Gehmert","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cgh.2019.06.028_bib22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/hep.25745","article-title":"Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma","volume":"56","author":"Shan","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.06.028_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.06.028_bib24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/hep.30330","article-title":"Magnetic resonance imaging is cost-effective for hepatocellular carcinoma surveillance in high risk patients with cirrhosis","volume":"69","author":"Kim","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.06.028_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/jamaoncol.2016.3147","article-title":"MRI with liver-specific contrast for surveillance of patients with cirrhosis at high risk of hepatocellular carcinoma","volume":"3","author":"Kim","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cgh.2019.06.028_bib26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3349\/ymj.2018.59.8.912","article-title":"Stereotactic body radiotherapy: does it have a role in management of hepatocellular carcinoma?","volume":"59","author":"Choi","year":"2018","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.cgh.2019.06.028_bib27","first-page":"95","article-title":"Unenhanced MRI versus ultrasonography for hepatocellular carcinoma surveillance: preliminary results of a prospective randomized trial (MIRACLE-HCC)","volume":"7","author":"Rhee","year":"2018","journal-title":"Liver Cancer"},{"key":"10.1016\/j.cgh.2019.06.028_bib28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/j.gastro.2017.07.001","article-title":"Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B: a large cohort study","volume":"153","author":"Yu","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.06.028_bib29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2019.06.028_bib30","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2004.08.052","article-title":"Serum markers detect the presence of liver fibrosis: a cohort study","volume":"127","author":"Rosenberg","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.06.028_bib31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3851\/IMP1982","article-title":"HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B","volume":"16","author":"Kim","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cgh.2019.06.028_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3350\/cmh.2017.0104","article-title":"Current status and strategies for hepatitis B control in Korea","volume":"23","author":"Cho","year":"2017","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.cgh.2019.06.028_bib33","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27735","article-title":"Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis","volume":"61","author":"Kim","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.06.028_bib34","doi-asserted-by":"crossref","unstructured":"Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol 2019;25:93\u2013159.","DOI":"10.3350\/cmh.2019.1002"},{"key":"10.1016\/j.cgh.2019.06.028_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3350\/cmh.2016.0086","article-title":"Risk score model for the development of hepatocellular carcinoma in treatment-na\u00efve patients receiving oral antiviral treatment for chronic hepatitis B","volume":"23","author":"Sohn","year":"2017","journal-title":"Clin Mol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519306664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519306664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:29:59Z","timestamp":1761542999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356519306664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1542356519306664"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2019.06.028","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2019.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}